Anti-interleukin-1 therapy with canacinumab and anakinra in patients with histologically proven AA amyloidosis secondary to Familial Mediterranean Fever
Latest Information Update: 11 Aug 2016
At a glance
- Drugs Canakinumab (Primary) ; Anakinra; Colchicine
- Indications Familial Mediterranean fever
- Focus Adverse reactions; Therapeutic Use
- 11 Aug 2016 New trial record